Professor Richard Adams
Prosiectau fel Prif Ymchwiliwr
- Access to AML data (01.08.2015 - 30.04.2018)
- Adults with acute myeloid leukaemia or high-risk myelodysplastic syndrome (16.09.2015 - 31.08.2025)
- Adults with acute myeloid leukaemia or high risk myelodysplastic syndrome - AML19
(30.07.2015 - 31.07.2022) - AML 17 Supply agreement (29.04.2009 - 15.11.2019)
- AML 18 - A trial for older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome (01.06.2013 - 31.07.2024)
Prosiectau fel Cyd-Ymchwiliwr
- Preparing healthcare providers and the public for Multi Cancer Early Detection (MCED) blood tests: towards equitable implementation through co-creation (01.05.2024 - 30.04.2025)
- Pressurised IntraPeritoneal Aerosolised Chemotherapy (PIPAC) in Cancers of the Colon Ovaries and Stomach (01.11.2022 - 31.12.2026)
- Prospective collection of acute myeloid leukaemia samples within the NCRI AML trials (01.07.2018 - 30.06.2025)
- Rapid Protection: An adaptive clinical trial of AZD7442 and Vaxzevria (AZD1222/ChAdOx1 nCoV-19) in immunosuppressed patients that are highly vulnerable to infection with SARS-CoV-2 virus (01.12.2021 - 30.11.2024)
- RT3 VIN: A randomised phase II multi-centre trial of topical treatment in women with vulval intraepithelial neoplasia (01.11.2006 - 31.05.2016)